Cell No. : Cell Name RCB5930 : S+L-HOS/HTLV-1_MEL5  update : 2024/11/22
Comment			BSL2. Currently not ready. We don't know whether virus particles are produced or not. Therefore, the cells must be handled under BSL2.
Comment from the depositor			S+L-HOS/HTLV-1MEL5 cells were HTLV-1 producing cells after cocultivation of Moloney murine sarcoma virus-positive S+L-HOS cells with lethally irradiated HTLV-1-positive human T-cell line (SI-5).
Terms and conditions
Remarks
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
		BSL	BSL2
Reference information		Reference	2
		User's Publication	0

Top

Reference

17386  Soda Y, Jinno A, Tanaka Y, Akagi T, Shimotohno K, Hoshino H.  Rapid tumor formation and development of neutrophilia and splenomegaly in nude mice transplanted with human cells expressing human T cell leukemia virus type I or Tax1  Leukemia  2000  14(8):1467-76  PubMed ID: 10942244   DOI: 10.1038/sj.leu.2401844

17389  Rhim JS.  Characterization of sarcoma-positive, leukemia-negative (S+L-) human cells induced by the feline leukemia virus pseudotype of Moloney sarcoma virus  Proc Soc Exp Biol Med  1981  167(4):597-606  PubMed ID: 6269117   DOI: 10.3181/00379727-167-41221

Top

User's Publication